← All stocks

ADC Therapeutics SA

ADCT Net selling
CIK 0001771910 #4222 in the set updated 19 Sep 2026
Bought (120 mo)
$2.86M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$19.91M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$19.91M
15 of 15 sales
Net
−$17.06M
−$17.06M against sales at will

By person

15 insiders · 21 transactions
8.9×

Ameet Mallik holds 8.9 times base salary in stock. $6.96M of shares against $776.08K in salary for 2025.

Salary from the company's own proxy. The shares are what Ameet Mallik last reported holding, valued at $3.28, the price Common Stock was last bought or sold at on the open market here, on 2 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Redmile Group, LLC entity
10% owner
$2.86M (6)
$19.69M (7)
−$16.83M
51,744,471
$169.67M
−8.6%
MALLIK AMEET
Chief Executive Officer
$133.19K (1)
−$133.19K
2,121,769
$6.96M
+301.9%
Azelby Robert
Director
$20.22K (1)
−$20.22K
112,805
$369.89K
+464.0%
BIZZARI JEAN-PIERRE
Director
$20.22K (1)
−$20.22K
139,302
$456.77K
+199.6%
Sandor Victor
Director
$20.22K (1)
−$20.22K
140,686
$461.31K
+193.8%
Squarer Ron
Director
$20.22K (1)
−$20.22K
123,431
$404.73K
+244.7%
Monges Viviane
Director
$4.15K (1)
−$4.15K
186,447
$611.36K
+173.9%
Pfisterer Thomas
See Explanations
$4.15K (1)
−$4.15K
173,899
$570.21K
−70.4%
Hug Peter
Director
$3.45K (1)
−$3.45K
263,344
$863.50K
+83.1%
WILD HANS PETER
10% owner
9,788,944
$32.10M
Carmona Jose
Chief Financial Officer
938,076
$3.08M
+168.0%
Zaki Mohamed
Chief Medical Officer
896,317
$2.94M
+232.0%
GRAHAM PETER J
Chief Legal Officer
841,640
$2.76M
+265.9%
Kallebo Lisa Michelle
Chief Accounting Officer
128,224
$420.45K
+201.7%
Coughlin Timothy
Director
72,400
$237.40K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 70
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 16,880,797
History held since 9 Feb 2024